TABLE 2.
Hepatic 18F-FDGal Kinetics in Absence of Galactose
Subject no. | (L blood/min) | Approximation of | (L blood/min/L liver tissue) | ||
---|---|---|---|---|---|
1 | 0.41 ± 0.07 | 0.35 ± 0.06 | 85% | 0.265 ± 0.003 | |
2 | 0.33 ± 0.03 | 0.36 ± 0.04 | 84% | 0.213 ± 0.006 | |
3 | 0.50 ± 0.09 | 0.29 ± 0.06 | 87% | 0.279 ± 0.004 | |
4 | ND | ND | ND | 0.229 ± 0.008 | |
5 | 0.52 ± 0.09 | 0.39 ± 0.07 | 83% | 0.342 ± 0.004 | |
6 | 0.33 ± 0.04 | 0.35 ± 0.05 | 84% | 0.253 ± 0.004 | |
7 | 0.24 ± 0.06 | 0.27 ± 0.06 | 88% | 0.273 ± 0.002 | |
8 | 0.32 ± 0.06 | 0.29 ± 0.06 | 87% | 0.295 ± 0.008 | |
Mean ± SE | 0.38 ± 0.02 | 0.33 ± 0.02 | 85% | 0.274 ± 0.001 |
= intrinsic clearance of 18F-FDGal; F = hepatic blood flow (L blood/min; Table 1); = hepatic systemic clearance of 18F-FDGal; = hepatic systemic clearance of 18F-FDGal calculated from PET study without galactose infusion; ND = not determined (in subject 4, no liver vein blood samples were obtained during PET study); mean ± SE = weighted mean ± SE of the weighted mean.
Individual values are given as estimate ± SE of estimate.